← 홈

위암

143개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 143개
AntibodystaleHenan Cancer HospitalPhase 2

trastuzumab (Herceptin, fruquintinib＋trastuzumab + XELOX)

Gastric Adenocarcinoma; Gastric (Stomach) Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPreclinical

nivolumab (Opdivo, nivolumab + chemotherapy)

Gastric Adenocarcinoma; Gastro-esophageal Junction Adenocarcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Preclinical#항체#면역항체+3
효능 ORR 36.4%임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, nivolumab combined with SOX)

Immune Suppression; Gastric Cancer · Immune Suppression

#ImmuneSuppression#Antibody#Phase2#항체#면역항체+3
효능 ORR 27.8%임상시험 1상태 RECRUITING

8 / 8 페이지

← 이전다음 →